| P50 | author | Jyothi U Menon | Q63590749 |
| P2093 | author name string | Connie C W Hsia | |
| | Kytai T Nguyen | |
| | Dipendra Gyawali | |
| | Priya Ravikumar | |
| | Amruta Pise | |
| P2860 | cites work | Nanoparticles incorporated in pH-sensitive hydrogels as amoxicillin delivery for eradication of Helicobacter pylori | Q30897890 |
| | Effervescent dry powder for respiratory drug delivery | Q33266001 |
| | Improved cellular uptake of chitosan-modified PLGA nanospheres by A549 cells | Q33489112 |
| | Nanomedicine in pulmonary delivery | Q33572981 |
| | Shear-regulated uptake of nanoparticles by endothelial cells and development of endothelial-targeting nanoparticles. | Q33790279 |
| | Formulation, characterization and pulmonary deposition of nebulized celecoxib encapsulated nanostructured lipid carriers | Q33846935 |
| | Swellable microparticles as carriers for sustained pulmonary drug delivery | Q36846462 |
| | Nanoparticles for drug delivery to the lungs | Q36998692 |
| | Nanocarriers as pulmonary drug delivery systems to treat and to diagnose respiratory and non respiratory diseases | Q37167333 |
| | Nanocarriers for pulmonary administration of peptides and therapeutic proteins | Q37823598 |
| | Controlled pulmonary drug and gene delivery using polymeric nano-carriers | Q37970823 |
| | Engineered PLGA nano- and micro-carriers for pulmonary delivery: challenges and promises | Q38033610 |
| | Toxicity of surface-modified PLGA nanoparticles toward lung alveolar epithelial cells. | Q39142411 |
| | Influence of surface charge on the potential toxicity of PLGA nanoparticles towards Calu-3 cells. | Q39176625 |
| | Nanoparticle adhesion to the cell membrane and its effect on nanoparticle uptake efficiency | Q39213615 |
| | Folic acid and cell-penetrating peptide conjugated PLGA-PEG bifunctional nanoparticles for vincristine sulfate delivery | Q39314735 |
| | Effects of surfactants on the properties of PLGA nanoparticles | Q39352101 |
| | Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery | Q39467312 |
| | Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles | Q39742676 |
| | Layer-by-Layer-Coated Gelatin Nanoparticles as a Vehicle for Delivery of Natural Polyphenols | Q39836903 |
| | PLGA, chitosan or chitosan-coated PLGA microparticles for alveolar delivery? A comparative study of particle stability during nebulization. | Q40048971 |
| | Development of gelatin nanoparticles with biotinylated EGF conjugation for lung cancer targeting. | Q40119549 |
| | Chitosan nanoparticles are compatible with respiratory epithelial cells in vitro | Q40149665 |
| | PLGA-PEI nanoparticles for gene delivery to pulmonary epithelium | Q40543481 |
| | Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery | Q41847599 |
| | Pulmonary targeting of nanoparticle drug matrices | Q43067969 |
| | Effect of chitosan-alginate nanoparticles and ultrasound on the efficiency of gene transfection of human cancer cells | Q43234680 |
| | PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats | Q43557085 |
| | Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake | Q44054856 |
| | PLA/PLGA nanoparticles for sustained release of docetaxel. | Q44319563 |
| | Formulation and characterization of spray-dried powders containing nanoparticles for aerosol delivery to the lung | Q44714202 |
| | Non-phospholipid vesicles for pulmonary glucocorticoid delivery | Q45164872 |
| | PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution | Q45233463 |
| | Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles | Q46069080 |
| | Inhalable alginate nanoparticles as antitubercular drug carriers against experimental tuberculosis | Q46165852 |
| | PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery | Q46181738 |
| | Histological examination of PLGA nanospheres for intratracheal drug administration | Q46752853 |
| | Pulmonary drug delivery with aerosolizable nanoparticles in an ex vivo lung model | Q47302396 |
| | Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery | Q47375017 |
| | Calcium alginate nanoparticles synthesized through a novel interfacial cross-linking method as a potential protein drug delivery system. | Q48028075 |
| | Chitosan nanoparticle as protein delivery carrier--systematic examination of fabrication conditions for efficient loading and release. | Q50984653 |
| | Deposition of inhaled particles in the lungs. | Q51390643 |
| | Dry powders based on PLGA nanoparticles for pulmonary delivery of antibiotics: Modulation of encapsulation efficiency, release rate and lung deposition pattern by hydrophilic polymers | Q57718573 |
| | Microencapsulated chitosan nanoparticles for pulmonary protein delivery: In vivo evaluation of insulin-loaded formulations | Q60467876 |
| | Development of a new drug carrier made from alginate | Q72578239 |
| | Surfactant-polymer nanoparticles overcome P-glycoprotein-mediated drug efflux | Q80810089 |
| | Design and evaluation of inhalable chitosan-modified poly (DL-lactic-co-glycolic acid) nanocomposite particles | Q84344433 |
| P433 | issue | 6 | |
| P921 | main subject | nanoparticle | Q61231 |
| P304 | page(s) | 2643-2652 | |
| P577 | publication date | 2014-02-08 | |
| P1433 | published in | Acta Biomaterialia | Q4676719 |
| P1476 | title | Polymeric nanoparticles for pulmonary protein and DNA delivery | |
| P478 | volume | 10 | |